DNA hypomethylation as Achilles' heel of tumorigenesis: A working hypothesis

Cell Biology International

Volumn 33, Issue 8, 2009, Pages 904-910

  Shvachko, L P ^a  

^a INSTITUTE OF MOLECULAR BIOLOGY AND GENETICS   (Ukraine)

Author keywords

5 Azacytidine; DNA hypomethylation; Latent polytene heterochromatinization; Pericentromeric heterochromatin; Somatic cancer cell biology

Indexed keywords

AZACITIDINE; GENOMIC DNA;

ARTICLE; CANCER GROWTH; CARCINOGENESIS; CARCINOMA; CHROMOSOMAL INSTABILITY; DNA CONTENT; DNA HYPOMETHYLATION; DNA METHYLATION; EPIGENETICS; GENETIC STABILITY; HETEROCHROMATIN; HUMAN; MALIGNANT TRANSFORMATION; MITOSIS; PERIPHERAL LYMPHOCYTE; PLOIDY; SOMATIC CELL;

AZACITIDINE; DNA METHYLATION; EPIGENESIS, GENETIC; HETEROCHROMATIN; INTERPHASE; KARYOTYPING; LYMPHOCYTES; METAPHASE; NEOPLASMS; PLOIDIES;

EID: 68049102037     PISSN: 10656995     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellbi.2009.02.018     Document Type: Article

References (74)

1. Ballestar E., and Esteller M. The epigenetic breakdown of cancer cells: from DNA methylation to histone modifications. Prog Mol Subcell Biol 38 (2005) 169-181
2. Baylin S., and Bestor T. Altered methylation pattern in cancer cell genomes: cause or consequence?. Cancer Cell 1 (2002) 299-305
3. Baylin S., and Herman J. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet 16 (2000) 168-174
4. Baylin S., Herman J., Graff J., Vertino P., and Issa J.-P. Alterations in DNA methylation - a fundamental aspect of neoplasia. Adv Cancer Res 72 (1998) 141-196
5. Brock M., Herman J., and Baylin S. Cancer as a manifestation of aberrant chromatin structure. Cancer J 13 (2007) 3-8
6. Chen R., Pettersson U., Beard C., Jackson-Grusby L., and Jaenisch R. DNA hypomethylation leads to elevated mutation rates. Nature 395 (1998) 89-93
7. Chen T., Hevi S., Gay F., Tsujimoto N., He T., Zhang B., et al. Complete inactivation of DNMT1 leads to mitotic catastrophe in human cancer cells. Nat Genet 39 (2007) 391-396
8. Clark S., and Melki J. DNA methylation and gene silencing in cancer: which is the guilty party?. Oncogene 21 (2002) 5380-5387
9. Counts J., and Goodman J. Alterations in DNA methylation may play a variety of roles in carcinogenesis. Cell 83 (1995) 13-15
10. Cravo M. Global DNA hypomethylation in breast carcinoma (correlation with prognostic factors and tumor progression). Cancer 85 (1999) 112-118
11. D'Alessio A., and Szyf M. Epigenetic tete-a-tete: the bilateral relationship between chromatin modifications and DNA methylation. Biochem Cell Biol 84 (2002) 463-476
12. Eden A., Gaudet E., Waghmare A., and Jaenisch R. Chromosomal Instability and tumors promoted by DNA hypomethylation. Science 300 (2003) 455
13. Ehrlich M. DNA hypomethylation, cancer, the immunodeficiency, centromeric region instability, facial anomalies syndrome, and chromosomal rearrangements. J Nutr 132 (2002) 2424S-2429S
14. Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene 21 (2002) 5400-5413
15. Ehrlich M., Hopkins N.E., Jiang G., Dome J.S., Yu M.C., Woods C.B., et al. Satellite DNA hypomethylation in karyotyped Wilms tumors. Cancer Genet Cytogenet 141 2 (2003 Mar) 97-105
16. Esteller M., and Herman J. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol 196 (2002) 1-7
17. Feinberg A. The epigenetics of cancer etiology. Semin Cancer Biol 14 (2004) 427-432
18. Feinberg A., and Vogelstein B. Hypomethylation distinguishes genes of some human cancers from their normal counterparts. Nature 301 (1983) 89-92
19. Feinberg A., Ohlsson R., and Henikoff S. The epigenetic progenitor origin of human cancer. Nat Rev Genet 7 (2006) 21-33
20. Fraga M., Herranz M., Espada J., Ballestar E., Paz M., Ropero S., et al. A mouse skin multistage carcinogenesis model reflects the aberrant DNA methylation patterns of human tumors. Cancer Res 64 (2004) 5527-5534
21. Ganina K., Borodai N., Petunin I., and Klinshin D. Quantitative evaluation of DNA in the nuclei of buccal epithelium in fibroadenoma, fibroadenomatosis and breast cancer. Exp Oncol (Ukraine) 20 (1998) 130-134 (Russian)
22. Garinis G., Patrinos G., Spanakis N., and Menounos P. DNA hypermethylation: when tumour suppressor genes go silent. Hum Genet 111 (2002) 115-127
23. Gaudet F., Hodgson J., Eden A., Jackson-Grusby L., Dausman J., Gray J., et al. Induction of tumors in mice by genomic hypomethylation. Science 300 (2003) 489-492
24. Grunau C., Sanchez C., Ehrlich M., van der Bruggen P., Hindermann W., Rodriguez C., et al. Frequent DNA hypomethylation of human juxtacentromeric BAGE loci in cancer. Genes Chromosomes Cancer 43 1 (2005 May) 11-24
25. Habets G., van der Kammen R., Scholtes E., and Collard J. Induction of invasive and metastatic potential in mouse T-lymphoma cells (BW5147) by treatment with 5-azacytidine. Clin Exp Metastasis 8 (1990) 567-577
26. Haslberger A., Varga F., and Karlic H. Recursive causality in evolution: a model for epigenetic mechanisms in cancer development. Med Hypotheses 67 (2006) 1448-1454
27. Herman J. Epigenetic changes in cancer and preneoplasia. Cold Spring Harb Symp Quant Biol 70 (2005) 329-333
28. Herman J., and Baylin S. Promoter-region hypermethylation and gene silencing in human cancer. Curr Top Microbiol Immunol 249 (2000) 35-54
29. Herranz M., and Esteller M. New therapeutic targets in cancer: the epigenetic connection. Clin Transl Oncol 8 (2006) 242-249
30. Hoffmann M., and Schulz W. Causes and consequences of DNA hypomethylation in human cancer. Biochem Cell Biol 83 (2005) 246-321
31. Jones P. The DNA methylation paradox. Trend Genet 15 (1998) 34-37
32. Jones P., and Baylin S. The fundamental role of epigenetic events in cancer. Nat Rev Genet 3 (2002) 415-428
33. Jones P., and Baylin S. The epigenomics of cancer. Cell 128 (2007) 683-692
34. Karpf A., and Matsui S.-I. Genetic disruption of cytosine DNA methyltransferase enzymes induces chromosomal instability in human cancer cells. Cancer Res 65 (2005) 8635-8639
35. Kisseljova N., and Kisseljov F. DNA demethylation and carcinogenesis. Biochemistry (Mosc) 70 (2005) 743-752
36. In: Klaus G. (Ed). Lymphocytes, a practical approach (1987), IRL Press, Oxford 195
37. Kourmouli N., Sun Y., van der Sar S., Singh P., and Brown J. Epigenetic regulation of mammalian pericentric heterochromatin in vivo by HP1. Biochem Biophys Res Commun 337 (2005) 901-907
38. Laird P. Cancer epigenetics. Hum Mol Genet 14 (2005) R65-R76
39. Lewis J., and Bird A. DNA methylation and chromatin structure. FEBS Lett 5 (1991) 155-159
40. Lin C., Hsieh S., Sheen I., Lee W., Chen T., Shyn W., et al. Genome-wide hypomethylation in hepatocellular carcinogenesis. Cancer Res 61 (2001) 239-245
41. Momparler R. Epigenetic therapy of cancer with 5-aza-2′-deoxycytidine (decitabine). Semin Oncol 32 (2005) 443-451
42. Muegge K. Lsh, a guardian of heterochromatin at repeat elements. Biochem. Cell Biol 83 (2005) 548-554
43. Muller H., Widschwendter A., Fiegl H., Goebel G., and Wiedemair A. DNA methylation pattern similar to normal tissue is associated with better prognosis in human cervical cancer. Cancer Lett 299 (2004) 231-236
44. Nusse M., Miller B., Viaggi S., and Grawe J. Analysis of the DNA content distribution of micronuclei using flow sorting and fluorescent in situ hybridization with a centromeric DNA probe. Mutagenesis 11 (1996) 405-413
45. Paz M., Fraga M., Avila S., Guo M., Pollan M., Herman J., et al. A systematic profile of DNA methylation in human cancer cell lines. Cancer Res 63 (2003) 1114-1121
46. Pinto A., Andre S., Nogueira M., Mendonca E., and Soares J. Flow cytometric DNA hypertetraploidy is associated with unfavourable prognostic features in breast cancer. J Clin Pathol 50 (1997) 591-595
47. Pinto A., Fonseca I., and Soares J. DNA flow cytrometry in solid tumors. Acta Med Port 15 (2002) 133-142
48. Pogribny I., James S., Jemigan S., and Pogribna M. Genomic hypomethylation is specific for preneoplastic liver in folate/methyl deficient rats and does not occur in non-target tissue. Mutation Res 548 (2004) 53-59
49. Pogribny I., Ross S., Wise C., Pogribna M., Jones E., Tryndyak V., et al. Irreversible global DNA hypomethylation as a key step in hepatocarcinogenesis induced by dietary methyl deficiency. Mutation Res 593 (2006) 80-87
50. Ponder B.A. Cancer genetics. Nature 411 (2001) 336-341
51. Qu G., Dubeau L., Narayan A., Yu M., and Ehrlich M. Satellite DNA hypomethylation vs. overall genomic hypomethylation in ovarian epithelial tumors of different malignant potential. Mutation Res 423 (1999) 91-101
52. Rhee I., Jair K., Yen R., Lengauer C., Herman J., Kinzle K., et al. CpG methylation is maintained in human cancer cells lacking DNMT1. Nature (London) 404 (2000) 1003-1007
53. Robertson K. DNA methylation and chromatin. Oncogene 21 (2002) 5361-5379
54. Rodriguez J., Fridola J., Vendrell E., Risques R.-A., Fraga M., Morales C., et al. Chromosome instability correlates with genome-wide DNA demethylation in human primary colorectal cancer. Cancer Res 66 (2006) 8462-8468
55. Rountree M., Bachman K., Herman J., and Baylin S. DNA methylation, chromatin inheritance, and cancer. Oncogene 20 (2001) 3156-3165
56. Shames D., Minna J., and Gazdar A. DNA methylation in health, disease, and cancer. Curr Mol Med 7 (2007) 85-102
57. Sherr C. Principles of tumor suppression. Cell 116 (2004) 235-246
58. Shvachko L. The correlation relationships between cancer-associated pattern genome DNA hypomethylation and mitotic interphase nuclear heterochromatinization contributing to carcinogenesis. Proc Biol Med 2 (2008) 38-45 (Ukraine)
59. Shvachko L., Buck I., Stepanenko A., Procyk V., Kikotj V., Klimnjuk G., et al. The method of early detection of cancer. Declaration Patent of Ukraine 4 (2006) UA 13616 (Ukrainian)
60. Somasundaram K., Mungamuri S., and Wajapeyee N. DNA microarray technology and its applications in cancer biology. Appl Genomics Proteomics 1 (2002) 1-10
61. Sonnenschein C., and Soto A. The society of cells; cancer and control of cell proliferation (1999), Springer Verlag, New York
62. Sonnenschein C., and Soto A. Somatic mutation theory of carcinogenesis: why it should be dropped and replaced. Mol Carcinog 29 (2001) 205-211
63. Soto A., and Sonnenschein C. Problems and paradigms. The somatic mutation theory of cancer: growing problems with the paradigm?. BioEssays 26 (2004) 1097-1107
64. Stefanova V, Chyryaeva O, Smirnov A. The influence of 5-azacytidine on the structure-function organization of mitotic chromosomes. IV All-Union symposium "Molecular mechanisms of genetics processes". 3-6 February, Moscow, Proceedings; 1987. p. 49 (Russian).
65. Szif M. Therapeutic implications of DNA methylation. Future Oncol 1 (2005) 125-135
66. Szyf M. DNA methylation and demethylation as targets for anticancer therapy. Biochemistry (Moscow) 70 (2005) 533-549
67. Szyf M. Targeting DNA methylation in cancer. Bull Cancer 93 (2006) 961-972
68. Szyf M., Pakneshan P., and Rabbani S. DNA demethylation and cancer: therapeutic implications. Cancer Lett 211 (2004) 133-143
69. Verma M., and Srivastava S. Epigenetics in cancer: implications for early detection and prevention. Lancet Oncol 3 (2002) 755-763
70. Wajed S., Laird P., and DeMeester T. DNA methylation: an alternative pathway to cancer. Ann Surg 234 (2001) 10-20
71. Widschwendter M., Jiang G., Woods C., Muller H., Fiegl H., Goebel G., et al. DNA hypomethylation and ovarian cancer biology. Cancer Res 64 (2004) 4472-4480
72. Worm J., and Guldberg P. DNA methylation: an epigenetic pathway to cancer and a promising target for anticancer therapy. J Oral Pathol Med 31 (2002) 443-449
73. Xu G., Bestor T., Bourc'his D., Hsieh C., Tommerup N., Bugge M., et al. Chromosome instability and immunodeficiency syndrome caused by mutations in a DNA methyltransferase gene. Nature (London) 402 (1999) 187-191
74. Zhimulev I. The chromomere organization of polytene chromosomes. Novosybirsk VO Science (1994) 565 (Russian)